Systemic treatment
Phase 3Completed 1 views this week 0 watching⚡ Active
Interest: 40/100
40
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Colon Cancer
Conditions
Colon Cancer, Primary Tumour, Rectal Cancer
Trial Timeline
Jul 1, 2012 → Dec 1, 2022
NCT ID
NCT01606098About Systemic treatment
Systemic treatment is a phase 3 stage product being developed by Roche for Colon Cancer. The current trial status is completed. This product is registered under clinical trial identifier NCT01606098. Target conditions include Colon Cancer, Primary Tumour, Rectal Cancer.
What happened to similar drugs?
4 of 13 similar drugs in Colon Cancer were approved
Approved (4) Terminated (5) Active (5)
Hype Score Breakdown
Clinical
17
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01606098 | Phase 3 | Completed |
Competing Products
20 competing products in Colon Cancer